SEC Form 4 · accession 0001179110-15-009742
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald G Payan
Officer — EVP, Pres. Discovery&Research · Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 12, 2015 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2015 | M | 41,666 | $2.14 | A | 100,000 | D | |
| Common Stock | Jun 10, 2015 | S | 41,666 | $3.6772 | D | 58,334 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.14 | Jun 10, 2015 | M | 41,666 | D | — | Jan 26, 2025 | Common Stock | 41,666 | 158,334 | D |
Explanation of responses
- F1The shares vest monthly over two (2) years from January 1, 2015.